Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia.
Sergi Torramade-MoixMarta PalomoManel VeraDidac JerezAna Belen Moreno-CastañoM Urooj ZafarJordi RoviraFritz DiekmannJoan Carles Garcia-PaganGines EscolarAleix CasesMaribel Díaz-RicartPublished in: Cardiovascular drugs and therapy (2020)
Anti-FXa strategies, such as apixaban, prevented ED caused by the uremic milieu, exhibiting anti-inflammatory and antioxidant properties and modulating the reactivity of the ECM.
Keyphrases